Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

TELEFLEX INCORPORATED

(TFX)
  Report
Delayed Nyse  -  04:04 2022-10-03 pm EDT
208.50 USD   +3.49%
09/28Teleflex launches new Arrow Pressure Injectable Midline Catheter Portfolio
AQ
09/28Teleflex Completes Acquisition of Standard Bariatrics
MT
09/28Teleflex Completes Acquisition of Standard Bariatrics
GL
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Quotes 5-day view   Delayed Quote. Delayed Nyse
09/27/2022 09/28/2022 09/29/2022 09/30/2022 10/03/2022 Date
201.97(c) 207.96(c) 203.97(c) 201.46(c) 208.5(c) Last
302 578 316 374 277 099 412 816 411 392 Volume
-1.16% +2.97% -1.92% -1.23% +3.49% Change
More quotes
Estimated financial data (e) (USD)
Sales 2022 2 809 M - -
Net income 2022 409 M - -
Net Debt 2022 1 060 M - -
P/E ratio 2022 24,1x
Yield 2022 0,65%
Sales 2023 2 952 M - -
Net income 2023 470 M - -
Net Debt 2023 503 M - -
P/E ratio 2023 21,1x
Yield 2023 0,66%
Capitalization 9 779 M 9 779 M -
EV / Sales 2022 3,86x
EV / Sales 2023 3,48x
Nbr of Employees 14 000
Free-Float 97,6%
More Financials
Company
Teleflex Incorporated specialises in the designing, manufacturing and selling of single-use medical devices for hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. Products are sold under the brand names Arrow«, Deknatel«, Hudson RCI«, LMA«, Pilling«, Rusch« and Weck«. Net sales break down by category of products as follows: -... 
More about the company
Ratings of Teleflex Incorporated
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B+
More Ratings
All news about TELEFLEX INCORPORATED
09/28Teleflex launches new Arrow Pressure Injectable Midline Catheter Portfolio
AQ
09/28Teleflex Completes Acquisition of Standard Bariatrics
MT
09/28Teleflex Completes Acquisition of Standard Bariatrics
GL
09/28Teleflex Completes Acquisition of Standard Bariatrics
AQ
09/28Teleflex Incorporated completed the acquisition of Standard Bariatrics, Inc.
CI
09/27Teleflex launches new Arrow« Pressure Injectable Midline Catheter Portfolio
GL
09/27Teleflex launches new Arrow« Pressure Injectable Midline Catheter Portfolio
AQ
09/27Teleflex Incorporated Launches New Arrow« Pressure Injectable Midline Catheter Portfoli..
CI
09/22Truist Securities Lowers Teleflex's Price Target to $241 From $265, Maintains Hold Rati..
MT
09/21Predicting The Unpredictable – When Is A Combination Obvious?
AQ
09/16Teleflex Incorporated - Co-Author of the Karolinska 1000 Consecutive MANTA Vascular Clo..
AQ
09/15Co-Author of the Karolinska 1000 Consecutive MANTA« Vascular Closure Device Study to Pr..
GL
09/15Co-Author of the Karolinska 1000 Consecutive MANTA« Vascular Closure Device Study to Pr..
AQ
09/14Transcript : Teleflex Incorporated Presents at Morgan Stanley 20th Annual Glo..
CI
08/31Teleflex to Present at the Morgan Stanley 20th Annual Global Healthcare Conference
GL
More news
News in other languages on TELEFLEX INCORPORATED
09/28Teleflex achève l'acquisition de Standard Bariatrics
09/27Teleflex Incorporated lance la nouvelle gamme de cathéters de ligne médiane injectables..
08/25Teleflex Incorporated collabore avec FundamentalVR pour améliorer la formation par la s..
08/22Teleflex accepte d'acheter Standard Bariatrics
08/01Teleflex remporte un contrat de fourniture avec Vizient
More news
Analyst Recommendations on TELEFLEX INCORPORATED
More recommendations
ETFs positioned on TELEFLEX INCORPORATEDETFs and Trackers with Trackinsight
ETF WeightVar. 5daysRatingGeography
Invesco S&P 500« Equal Weight Health Care E...1.36%2.52%United_States
BMO Equal Weight US Health Care Index ETF - CAD1.13%1.75%United_States
BMO Equal Weight U.S. Health Care Hedged to...1.03%2.68%United_States
IShares U.S. Medical Devices ETF - USD1.01%2.15%United_States
Invesco Zacks Mid-Cap ETF - USD0.91%1.45%United_States
More ETFs positioned on TELEFLEX INCORPORATED
Chart TELEFLEX INCORPORATED
Duration : Period :
Teleflex Incorporated Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends TELEFLEX INCORPORATED
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 12
Last Close Price 208,50 $
Average target price 275,82 $
Spread / Average Target 32,3%
EPS Revisions
Managers and Directors
Liam J. Kelly Chairman, President & Chief Executive Officer
Thomas E. Powell Chief Financial Officer & Executive Vice President
Timothy F. Duffy Chief Information Officer & Vice President
Michelle Fox Chief Medical Officer & Vice President
Justin McMurray VP-Global Strategic Research & Development
Sector and Competitors
1st jan.Capi. (M$)
TELEFLEX INCORPORATED-36.53%9 779
ABBOTT LABORATORIES-29.29%174 281
MEDTRONIC PLC-20.06%109 921
BECTON, DICKINSON AND COMPANY-6.10%65 817
HOYA CORPORATION-18.82%34 410
DEXCOM, INC.-36.69%33 362